Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A

Developmental Neurorehabilitation

Volumn 12, Issue 3, 2009, Pages 128-138

  Guettard, Emilie ^a,b   Roze, Emmanuel ^c,d,e   Abada, Genevieve ^a   Lemesle, Catherine ^a   Vidailhet, Marie ^d,e   Laurent Vannier, Anne ^a   Chevignard, Mathilde P ^a,d  

^a Hospital National de Saint Maurice   (France)

^b HÔPITAL FERNAND WIDAL   (France)

^c CNRS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Acquired brain injury; Botulinum toxin; Dystonia; Rehabilitation; Spasticity

Indexed keywords

BOTULINUM TOXIN A; EMLA; HYDROXYZINE; INHALATION ANESTHETIC AGENT; MEOPA; PARACETAMOL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANALGESIA; ARM MUSCLE; ARTICLE; BONE MALFORMATION; BRAIN INJURY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DYSTONIA; ELECTROSTIMULATION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; GAIT; GONIOMETRY; GRIP STRENGTH; HUMAN; INJECTION SITE PAIN; LEG MUSCLE; MALE; MONOTHERAPY; MOTOR PERFORMANCE; MUSCLE TRAINING; MUSCLE WEAKNESS; MYALGIA; OCCUPATIONAL THERAPY; PEDIATRIC PHYSIOTHERAPY; PEDIATRIC REHABILITATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SCHOOL CHILD; SPASTICITY; THERAPY EFFECT; TREATMENT RESPONSE; CLINICAL TRIAL; CONVALESCENCE; DRUG EFFECT; METHODOLOGY; PAIN; PAIN ASSESSMENT; PHYSIOTHERAPY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; BOTULINUM TOXIN TYPE A; BRAIN INJURIES; CHILD; CHILD, PRESCHOOL; DYSTONIA; FEMALE; FOLLOW-UP STUDIES; GAIT; HUMANS; MALE; MUSCLE SPASTICITY; OCCUPATIONAL THERAPY; PAIN; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349229632     PISSN: 17518423     EISSN: 17518431     Source Type: Journal    
DOI: 10.1080/17518420902927994     Document Type: Article

References (54)

1. Adelson PD, Kochanek PM. Head injury in children. Journal of Child Neurology 1998;13:2-15.
2. Adelson PD, Clyde B, Kochanek PM, Wisniewski SR, Marion DW, Yonas H. Cerebrovascular response in infants and young children following severe traumatic brain injury: A preliminary report. Pediatric Neurosurgery 1997;26:200-207.
3. Gedeit R. Head injury. Pediatrics in review/American Academy of Pediatrics 2001;22:118-124.
4. Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics 2004;114:206-212.
5. Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: A study of incidence and clinical features from 1985 to 1993. Journal of Clinical Epidemiology 1995;48:1343-1348.
6. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002;109:116-123.
7. Broderick J, Talbot GT, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: The surprising importance of intracerebral hemorrhage. Journal of Child Neurology 1993;8:250-255.
8. Meyer-Heim AD, Boltshauser E. Spontaneous intracranial haemorrhage in children: Aetiology, presentation and outcome. Brain Development 2003;2:416-421.
9. Grandgirard D, Leib SL. Strategies to prevent neuronal damage in paediatric bacterial meningitis. Current Opinions in Pediatrics 2006;18:112-118.
10. Rickert CH, Probst-Cousin S, Gullotta F. Primary intracranial neoplasms of infancy and early childhood. Childs Nervous System 1997;13:507-513.
11. Carney N, du Coudray H, Davis-O'Reilly C, Zimmer- Gembeck M, Mann NC, Krages KP, Helfand M, et al. Rehabilitation for traumatic brain injury in children and adolescents. Evidence Reports in Technology Assessment 1999;2(Supp l):1-5.
12. O'Flaherty S, Waugh MC. Pharmacologic management of the spastic and dystonic upper limb in children with cerebral palsy. Hand Clinics 2003;19:585-589.
13. Yelnik AP, Bonan IV. [Post stroke hemiplegia: Lower limb benefit from botulinum toxin (review)]. Annals of Readaptive Medical Physics 2003;46:281-285.
14. Roubertie A, Echenne B, Cif L, Vayssiere N, Hemm S, Coubes P. Treatment of early-onset dystonia: Update and a new perspective. Childs Nervous System 2000;16:334-340.
15. Simpson LL, Lautenslager GT, Kaiser II, Middlebrook JL. Identification of the site at which phospholipase A2 neurotoxins localize to produce their neuromuscular blocking effects. Toxicon 1993;31:13-26.
16. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;87:1044-1049.
17. Kabus C, Hecht M, Japp G, Jost WH, Pöhlau D, Stuckrad- Barre S, Winterholler M. Botulinum toxin in patients with multiple sclerosis. Journal of Neurology 2006;253:I26-I28.
18. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: A double-blind trial. Developmental Medicine and Child Neurology 1997;39:185-193.
19. Koman LA, Mooney JF, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group. Journal of Pediatric Orthopedics 2000;20:108-115.
20. Baker R, Jasinski M, Maciag-Tymecka I, Michalowska- Mrozek J, Bonikowski M, Carr L, MacLean J, Lin JP, Lynch B, Theologis T, Wendorff J, Eunson P, Cosgove A. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: A randomized, double-blind, placebo-controlled, doseranging study. Developmental Medicine and Child Neurology 2002;44:666-675.
21. Flett PJ, Stern LM, Waddy H, Connell TM, Seeger JD, Gibson SK. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. Journal of Paediatric Child Health 1999;35:71-77.
22. Autti-Rämö I, Larsen A, Taimo A, von Wendt L. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: Clinical implications. European. Journal of Neurology 2001;8:136-144.
23. Lowe K, Novak I, Cusick A. Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy. Developmental Medicine and Child Neurology 2007;49:823-829.
24. Lowe K, Novak I, Cusick A. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy. Developmental Medicine and Child Neurology 2006;48: 170-175.
25. Russo RN, Crotty M, Miller MD, Murchland S, Flett P, Haan E. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: A singleblind, randomized, controlled trial. Pediatrics 2007;119: 1149-1158.
26. Wallen M, O'Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: A randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2007;88:1-10.
27. Scholtes VA, Dallmeijer AJ, Knol DL, Speth LA, Maathuis CG, Jongerius PH, Becher JG. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy. Pediatric Neurology 2007;36:30-39.
28. Graham HK, Aoki KR, Autti-Rämö I, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley ME, Guyer BM, Heinen F, Holton AF, Matthews D, Molenaers G, Motta F, Garcia Ruiz PJ, Wissel J. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait & Posture 2000;11:67-79.
29. Heinen F, Molenaers G, Fairhurst C, Carr LJ, Desloovere K, Chaleat Valayer E, Morel E, Papavassiliou AS, Tedroff K, Ignacio Pascual-Pascual S, Bernert G, Berweck S, Di Rosa G, Kolanowski E, Krägeloh- Mann I. European consensus table 2006 on botulinum toxin for children with cerebral palsy. European Journal of Paediatric Neurology 2006;10:215-225.
30. Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70:1691-1698. (Pubitemid 351644137)
31. Mohamed KAMA, Rosenbloom L. Adverse events following repeated injections with botulinum toxin A in children with spasticity. Developmental Medicine and Child Neurology 2001;43:791-792.
32. Howell K, Selber P, Graham HK, Reddihough D. Botulinum neurotoxin A: An unusual systemic effect. Journal of Paediatric Child Health 2007;43:499-501.
33. Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic Botulinum toxin A injection in a pediatric patient. Clinical Neuropharmacology 2007;30: 310-313.
34. Coté TMA, Polder J, Walton M, Braun M. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. Journal of the American Academy of Dermatology 2005;53:407-415.
35. Bertrand H, Forin V. [Botulinum toxin type A in children: Evaluation of indications with a review of the literature]. Annals of Readaptive Medical Physics 2003;46:346-352.
36. Goldstein EM. Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. Journal of Child Neurology 2006;21:189-192.
37. Vanrhijn J, Molenaers G, Ceulemans B. Botulinum toxin type A in the treatment of children and adolescents with an acquired brain injury. Brain Injury 2005;19:331-335.
38. Mayer NHSD, ed. Dosing administration, and treatment algorithm for use of botulinum toxin A for adult-onset muscle overactivity in patients with an upper motoneuron lesion. New York: We Move ed.; 2002.
39. Desloovere K, Molenaers G, Jonkers I, De Cat J, De Borre L, Nijs J, Eyssen M, Pauwels P, De Cock P. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. European Journal of Neurology 2001;8:75-87.
40. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. The Practitioner 1964;192:540-542.
41. Zancolli EA, Goldner LJ, Swanson AB. Surgery of the spastic hand in cerebral palsy: Report of the Committee on Spastic Hand Evaluation (International Federation of Societies for Surgery of the Hand). Journal of Hand Surgery 1983; 8:766-772.
42. Heller A, Wade DT, Wood VA, Sunderland A, Hewer RL, Ward E. Arm function after stroke: Measurement and recovery over the first three months. Journal of Neurology, Neurosurgery and Psychiatry 1987;50:714-719. (Pubitemid 17076283)
43. Mathiowetz V, Volland G, Kashman N, Weber K. Adult norms for the Box and Block Test of manual dexterity. American Journal of Occupational Therapy 1985;39: 386-391.
44. Koman LA, Paterson Smith B, Balkrishnan R. Spasticityassociated with cerebral palsy in children: Guidelines for the use of botulinum A toxin. Paediatric 2003;5:11-23.
45. Naumann M, Albanese A, Heinen F, Molenaers G, Relja M. Safety and efficacy of botulinum toxin type A following longterm use. European Journal of Neurology 2006;13:35-40.
46. Wissel J, Heinen F, Schenkel A, Doll B, Ebersbach G, Mü ller J, Poewe W. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: A randomized, double-blind study of 'highdose' versus 'low-dose' treatment. Neuropediatrics 1999; 30:120-124.
47. Delgado MR, Wilson H, Johnston C, Richards S, Karol L. A preliminary report of the use of botulinum toxin type A in infants with clubfoot: Four case studies. Journal of Pediatric Orthopedics 2000;20:533-538.
48. Childers MK. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin. Physical Medicine Rehabilitation Clinis of North America 2003;14:781-792.
49. Molloy FM, Shill HA, Kaelin-Lang A, Karp BI. Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia. Neurology 2002;58:805-807.
50. Chin TY, Nattrass GR, Selber P, Graham HK. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: A comparison between manual needle placement and placement guided by electrical stimulation. Journal of Pediatric Orthopedics 2005;25:286-291.
51. Berweck S, Schroeder AS, Fietzek UM, Heinen F. Sonography-guided injection of botulinum toxin in children with cerebral palsy. Lancet 2004;363:249-250. (Pubitemid 38114736)
52. Delgado MR. The use of botulinum toxin type A in children with cerebral palsy: A retrospective study. European Journal of Neurology 1999;6:S11-S18.
53. Kawamura A, Campbell K, Lam-Damji S, Fehlings D. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity. Developmental Medicine and Child Neurology 2007;49:331-337.
54. Willis AW, Crowner B, Brunstrom JE, Kissel A, Racette BA. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy. Developmental Medicine and Child Neurology 2007;49: 818-822.